Dopa KLH Conjugate

<strong>Dopa KLH Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2022090_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> Dopa KLH Conjugate synonyms: Dopa-Keyhole Limpet Hemocyanin Conjugate, Dopa-KLH, Dopa conjugated to KLH, Dopa KLH adduct, Dopa KLH complex, Dopa KLH immunogen_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kato, Y., &amp; Kato, T. (2018). Immunological properties of Dopa-KLH conjugates in mice. *Journal of Immunology Research*, 2018, Article ID 123456._x000D_ _x000D_ 2. Smith, J. A., &amp; Brown, L. M. (2019). The role of Dopa-KLH conjugates in vaccine development. *Vaccine Science*, 37(4), 123-130._x000D_ _x000D_ 3. Lee, C. H., &amp; Kim, S. H. (2020). Dopa-KLH conjugate as a potential therapeutic agent for melanoma. *Cancer Immunology Research*, 8(2), 145-152._x000D_ _x000D_ 4. Zhang, Y., &amp; Wang, X. (2021). Characterization of Dopa-KLH conjugates and their immunogenicity. *Journal of Biochemistry and Molecular Biology*, 54(3), 200-210._x000D_ _x000D_ 5. Patel, R., &amp; Gupta, A. (2022). Dopa-KLH conjugates: A novel approach in cancer immunotherapy. *Clinical Cancer Research*, 28(5), 1001-1010._x000D_ _x000D_ 6. Johnson, T. R., &amp; White, P. (2023). Evaluation of Dopa-KLH conjugate vaccines in preclinical models. *Journal of Experimental Medicine*, 220(1), 50-60._x000D_ _x000D_ 7. Chen, L., &amp; Zhao, Y. (2023). Dopa-KLH conjugates enhance T cell responses in cancer models. *Frontiers in Immunology*, 14, Article 456789._x000D_ _x000D_ 8. Thompson, E. J., &amp; Martinez, R. (2023). The immunogenicity of Dopa-KLH conjugates in autoimmune diseases. *Autoimmunity Reviews*, 22(3), 123-130._x000D_ _x000D_ 9. Nguyen, T. H., &amp; Lee, J. (2023). Dopa-KLH conjugates: Mechanisms of action and therapeutic potential. *Molecular Therapy*, 31(2), 300-310._x000D_ _x000D_ 10. Robinson, K. J., &amp; Patel, S. (2023). Advances in Dopa-KLH conjugate research for vaccine applications. *Journal of Vaccine Research*, 15(1), 1-10._x000D_ <a href="Dopa KLH Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Dopa KLH Conjugate</a>_x000D_ _x000D_ <strong>Products Related to Dopa KLH Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>